Literature DB >> 4960741

Comparative effects of corticosteroids on host resistance to infection in relation to chemical structure.

R M Fauve, C H Pierce-Chase.   

Abstract

In a comparative study concerning the effect of corticosteroids on host resistance to infections, five compounds were found to decrease host resistance, while three did not have this property, although all eight compounds were highly antiinflammatory. The compounds capable of decreasing host resistance were (I) hydrocortisone acetate; (III) 9alpha-fluoro, 16alpha-methylprednisolone acetate; (IV) 9alpha-fluoro, 16alpha-hydroxyprednisolone; (V) 9alpha-fluoro, 16alpha-hydroxyprednisolone, 16alpha-17alpha-acetonide; and (VII) 9alpha-fluoro, 16alpha-hydroxypredmsolone, 16alpha-, 17alpha-acetonide, 21 disodium phosphate. Following a single injection of 10 mg of any of these compounds, latent corynebacterial infection was provoked into active pseudotuberculosis. Also, mice injected with these corticosteroids were more susceptible to infection with Corynebacterium kutscheri, Staphylococcus aureus, Klebsiella pneumoniae, or Listeria monocytogenes. These same corticosteroids inhibited the ability of mouse peritoneal macrophages to spread on glass surfaces. The three compounds incapable of decreasing host resistance, although highly antiinflammatory, were: (II) 6alpha-methylprednisolone, 21 sodium hemisuccinate: (VI) 9alpha-fluoro, 16alpha-hydroxyprednisolone, 16alpha-, 17alpha-acetonide, 21 hemisuccinate; and (VIII) 9alpha-fluoro, 16alpha-hydroxyprednisolone, 16, 21 dihemisuccinate. These three compounds were also unable to inhibit the spreading of macrophages on glass. The importance of succinate group bound to the corticosteroid molecule as hemisuccinate is emphasized since it is seen that the infection-provoking property can be dissociated from the antiinflammatory property. This finding may be of practical consequence in selecting a corticosteroid for treatment in disease, and also shows that one cannot use, indifferently, corticosteroids only on the basis of their common antiinflammatory property.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4960741      PMCID: PMC2138213          DOI: 10.1084/jem.125.5.807

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  COMPARISON OF ANTI-GRANULOMA, THYMOLYTIC AND GLUCOCORTICOID ACTIVITIES OF ANTI-INFLAMMATORY STEROIDS.

Authors:  L J LERNER; A R TURKHEIMER; A BIANCHI; F M SINGER; A BORMAN
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  Adrenal steroids and infection: the effect of cortisone administration on polymorphonuclear leukocytic functions and on serum opsonins and bactericidins.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

3.  Evaluation of infection-enhancing activity of modified corticoids.

Authors:  J K FRENKEL
Journal:  Proc Soc Exp Biol Med       Date:  1960-03

4.  Hormones and host resistance to infection.

Authors:  E H KASS
Journal:  Bacteriol Rev       Date:  1960-03

5.  Experimental observations with massive doses of cortisone.

Authors:  W ANTOPOL; S GLAUBACH; H QUITTNER
Journal:  Rheumatism       Date:  1951-01

6.  [Establishment of a pilot colony of NCS mice].

Authors:  R M Fauve; A Delaunay
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-02

7.  [Cellular resistance to bacterial infection. IV. Active immunization and resistance of the macrophages of NCS mice to the intracellular multiplication of Listeria monocytogenes, Corynebacterium kutscheri and Brucella melitensis].

Authors:  R M Fauve; D Bouanchaud; A Delaunay
Journal:  Ann Inst Pasteur (Paris)       Date:  1966-03

8.  FAILURE OF PRETREATMENT WITH GLUCOCORTICOIDS TO MODIFY THE PHAGOCYTIC AND BACTERICIDAL CAPACITY OF HUMAN LEUKOCYTES FOR ENCAPSULATED TYPE I PNEUMOCOCCUS.

Authors:  F ALLISON; M H ADCOCK
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

9.  Determinants of infection in the peritoneal cavity. II. Factors influencing the fate of Staphylococcus aureus in the mouse.

Authors:  Z A COHN
Journal:  Yale J Biol Med       Date:  1962-08

10.  CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. II. ACTIVATION OF NATURAL AND EXPERIMENTAL LATENT INFECTIONS.

Authors:  R M FAUVE; C H PIERCE-CHASE; R DUBOS
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

View more
  14 in total

1.  Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice.

Authors:  J H Cox; B C Knight; J Ivanyi
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Effect of hydrocortisone on the reactivity of thymus and spleen cells of mice to in vitro stimulation.

Authors:  T L Vischer
Journal:  Immunology       Date:  1972-11       Impact factor: 7.397

4.  Hydrocortisone and the migration of human leucocytes: an indirect effect mediated by mononuclear cells.

Authors:  R D Stevenson
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

5.  Experimental mycotic encephalitis.

Authors:  J A Swenberg; A Koestner; R P Tewari
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

6.  [Mechanism of action of corticoids in immunosuppression].

Authors:  T Diamantstein
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1970

7.  The effects of short-term steroid therapy on lung bacterial clearance and survival in rats.

Authors:  W A Skornik; D P Dressler
Journal:  Ann Surg       Date:  1974-04       Impact factor: 12.969

8.  Effect of antimicrobial therapy on lung bacterial clearance in the burned rat.

Authors:  D P Dressler; W A Skornik
Journal:  Ann Surg       Date:  1972-02       Impact factor: 12.969

9.  Corynebacterium kutscheri and its alleged avirulent variant in mice.

Authors:  R G Hirst; R J Olds
Journal:  J Hyg (Lond)       Date:  1978-06

10.  Effects of indomethacin on acute, subacute, and latent infections in mice and rats.

Authors:  H J Robinson; H F Phares; O E Graessle
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.